← Back to Manufacturing

Pharmaceutical Preparation Manufacturing

Industry Overview

Stock Screener

Select filters to narrow down the 519 companies below

519 companies
$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%
Market Cap
Dividends Ratio of dividends in the last 12 months to current share price
P/E Ratio
Revenue Revenue of the last quarter YoY Change
Net income Net income of the last quarter YoY Change
Profit margin Profit margin of the last quarter

Lilly(Eli) & Co

LLY

Lilly(Eli) & Co

LLY
Market Cap $1.03T
Dividends 0.6%
P/E Ratio 38.9
Revenue $19.8B +55.5%
Net Income $7.4B +168.0%
Profit Margin +37.4%
View Stock

Johnson & Johnson

JNJ

Johnson & Johnson

JNJ
Market Cap $549.78B
Dividends 2.3%
P/E Ratio 26.5
Revenue $24.1B +9.9%
Net Income $5.24B -52.4%
Profit Margin +21.8%
View Stock

Abbvie Inc

ABBV

Abbvie Inc

ABBV
Market Cap $382.74B
Dividends 3.1%
P/E Ratio 106.2
Revenue $15B +12.4%
Net Income $699M -45.6%
Profit Margin +4.7%
View Stock

Merck & Co Inc

MRK

Merck & Co Inc

MRK
Market Cap $281.24B
Dividends 3.0%
P/E Ratio 31.5
Revenue $16.3B +4.9%
Net Income -$4.24B -183.5%
Profit Margin -26.0%
View Stock

Abbott Laboratories

ABT

Abbott Laboratories

ABT
Market Cap $153.94B
Dividends 2.8%
P/E Ratio 24.6
Revenue $11.2B +7.8%
Net Income $1.08B -18.7%
Profit Margin +9.6%
View Stock

Pfizer Inc.

PFE

Pfizer Inc.

PFE
Market Cap $143.74B
Dividends 6.8%
P/E Ratio 19.2
Revenue $14.5B +5.4%
Net Income $2.69B -9.4%
Profit Margin +18.6%
View Stock

Vertex Pharmaceuticals, Inc.

VRTX

Vertex Pharmaceuticals, Inc.

VRTX
Market Cap $114.63B
Dividends 0.0%
P/E Ratio 26.5
Revenue $2.99B +7.8%
Net Income $1.03B +59.6%
Profit Margin +34.5%
View Stock

Bristol-Myers Squibb Co.

BMY

Bristol-Myers Squibb Co.

BMY
Market Cap $110.27B
Dividends 4.6%
P/E Ratio 15.2
Revenue $11.5B +2.6%
Net Income $2.68B +9.0%
Profit Margin +23.3%
Employees 30.25K
View Stock

Regeneron Pharmaceuticals, Inc.

REGN

Regeneron Pharmaceuticals, Inc.

REGN
Market Cap $62.84B
Dividends 0.6%
P/E Ratio 14.3
Revenue $3.61B +19.0%
Net Income $727M -10.1%
Profit Margin +20.2%
View Stock

Alnylam Pharmaceuticals Inc

ALNY

Alnylam Pharmaceuticals Inc

ALNY
Market Cap $37.13B
Dividends 0.0%
P/E Ratio 63.8
Revenue $1.17B +96.4%
Net Income $206M -458.4%
Profit Margin +17.6%
View Stock

Teva- Pharmaceutical Industries Ltd. - ADR

TEVA

Teva- Pharmaceutical Industries Ltd. - ADR

TEVA
Market Cap $36.66B
Dividends 0.0%
P/E Ratio 23.4
Revenue $3.98B +2.3%
Net Income $369M +72.4%
Profit Margin +9.3%
View Stock

Zoetis Inc - Ordinary Shares - Class A

ZTS

Zoetis Inc - Ordinary Shares - Class A

ZTS
Market Cap $33B
Dividends 2.6%
P/E Ratio 12.6
Revenue $2.26B +1.9%
Net Income $601M -4.8%
Profit Margin +26.6%
Employees 9.2K
View Stock

Horizon Therapeutics Plc

HZNP

Horizon Therapeutics Plc

HZNP
Market Cap $26.6B
Dividends 0.0%
P/E Ratio 51.1
Revenue $945M +7.8%
Net Income $127M +108.4%
Profit Margin +13.4%
View Stock

United Therapeutics Corp

UTHR

United Therapeutics Corp

UTHR
Market Cap $22.78B
Dividends 0.0%
P/E Ratio 18.1
Revenue $782M -1.6%
Net Income $275M -14.7%
Profit Margin +35.2%
Employees 920
View Stock

Insmed Inc

INSM

Insmed Inc

INSM
Market Cap $20.76B
Dividends 0.0%
P/E Ratio -17.4
Revenue $306M +229.6%
Net Income -$164M -36.3%
Profit Margin -53.5%
View Stock

BeiGene Ltd - ADR

BGNE

BeiGene Ltd - ADR

BGNE
Market Cap $20.21B
Dividends 0.0%
P/E Ratio 4.0
Revenue $1.51B +35.5%
Net Income $227M +17802.1%
Profit Margin +15.0%
View Stock

Eisai Co Ltd - ADR

ESALY

Eisai Co Ltd - ADR

ESALY
Market Cap $17.64B
Dividends 4.1%
P/E Ratio 28.5
Revenue $188B
Net Income $9.12B
Profit Margin +4.9%
View Stock

Ascendis Pharma A/S - ADR

ASND

Ascendis Pharma A/S - ADR

ASND
Market Cap $14.34B
Dividends 0.0%
P/E Ratio 24.6
Revenue $251M +148.3%
Net Income $640M -776.0%
Profit Margin +255.2%
View Stock

Jazz Pharmaceuticals plc

JAZZ

Jazz Pharmaceuticals plc

JAZZ
Market Cap $14.11B
Dividends 0.0%
P/E Ratio 471.5
Revenue $1.07B +19.1%
Net Income $293M -416.7%
Profit Margin +27.4%
Employees 1.21K
View Stock

Intra-Cellular Therapies Inc

ITCI

Intra-Cellular Therapies Inc

ITCI
Market Cap $14.05B
Dividends 0.0%
P/E Ratio -182.1
Revenue $199M +51.5%
Net Income -$16.9M -40.9%
Profit Margin -8.5%
View Stock